<table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col></col>
<col></col>
<col></col>
<tbody>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Drugs that Affect Renal          <br/>Function</td>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top"> A decline in GFR or tubular secretion, as from ACE inhibitors,          <br/>angiotensin receptor blockers, nonsteroidal anti-inflammatory drugs<br/>[NSAIDs], COX-2 inhibitors may impair the excretion of digoxin.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Antiarrthymics</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Dofetilide</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Concomitant administration with digoxin was associated with a higher rate of torsades de pointes.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">  </td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Sotalol</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top">  Proarrhythmic events were more common in patients receiving sotalol and digoxin than on either alone; it is not clear whether this represents an interaction or is related to the presence of CHF, a known risk factor for proarrhythmia, in patients receiving digoxin.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">  </td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Dronedarone</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Sudden death was more common in patients receiving digoxin with dronedarone than on either alone; it is not clear whether this represents an interaction or is related to the presence of advanced heart disease, a known risk factor for sudden death in patients receiving digoxin.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Parathyroid Hormone<br/>Analog</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Teriparatide</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Sporadic case reports have suggested that hypercalcemia may predispose patients to digitalis toxicity. Teriparatide transiently increases serum calcium.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Thyroid supplement</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Thyroid</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Treatment of hypothyroidism in patients taking digoxin may increase the dose requirements of digoxin.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Sympathomimetics</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Epinephrine Norepinephrine Dopamine</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Can increase the risk of cardiac arrhythmias.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Neuromuscular Blocking<br/>Agents</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Succinylcholine</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> May cause sudden extrusion of potassium from muscle cells, causing arrhythmias in patients taking digoxin.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Supplements</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top"> Calcium</td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> If administered rapidly by intravenous route, can produce serious arrhythmias in digitalized patients.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Beta-adrenergic blockers<br/>and calcium channel<br/>blockers</td>
<td stylecode="     Botrule          Toprule         Lrule     " valign="top">  </td>
<td stylecode="     Botrule          Toprule          Rrule     " valign="top"> Additive effects on AV node conduction can result in bradycardia and advanced or complete heart block.</td>
</tr>
<tr>
<td stylecode="     Botrule          Toprule         Lrule          Rrule     " valign="top">Ivabradine </td>
<td colspan="2" stylecode="     Botrule          Toprule         Lrule     " valign="top">Can increase the risk of bradycardia. </td>
</tr>
</tbody>
</table>